Syngene Q1 profit up 59% to Rs 87 crore
Syngene International's profit after tax surged 59% to Rs 87 crore in Q1 2025, driven by revenue growth and a tax benefit. Revenue from operations increased by 11% to Rs 875 crore, with EBITDA rising 19% to Rs 224 crore. The company is progressing with its Biologics Unit III and preparing to launch its Bayview site in the US.
Syngene International's profit after tax surged 59% to Rs 87 crore in Q1 2025, driven by revenue growth and a tax benefit. Revenue from operations increased by 11% to Rs 875 crore, with EBITDA rising 19% to Rs 224 crore. The company is progressing with its Biologics Unit III and preparing to launch its Bayview site in the US.
